Skip to content
Connect
Stories

Researchers are taking aim at the counterfeit drug and medical supplies market

People in this story

Photo by Matthew Modoono/Northeastern University

The skyrocketing demand for COVID-19 treatment has scientists working overtime to produce medicines and vaccines. But simply creating these therapies isn’t the only hurdle facing researchers and world leaders. 

Once a vaccine is developed, for example, it will inevitably be in short supply. And if rich countries continue to monopolize doses, poorer countries will be left to fend for themselves.  

Situations like this fuel the counterfeit drug market, says Nikos Passas, professor of criminology and criminal justice at Northeastern. When people are desperate, they’ll take whatever treatments they can get. And that can be incredibly dangerous to people’s health.

Continue reading at News@Northeastern.

More Stories

Alessandro Vespignani working at his desk

Northeastern receives $17.5 million from CDC to launch infectious disease prediction center

09.19.2023
US citizens Siamak Namazi (C-with glasses) and Morad Tahbaz are greeted upon their arrival at the Doha International Airport in Doha on September 18, 2023.

Ransom payment or effective negotiating? How the US freed five captive Americans in Iran

09.19.2023
Selenis Leyva attends the 'Orange Is The New Black' Final Season Premiere in New York.

Stand-up comedy and academic research converge in new speaker series ‘Latinxs and Comedy’

09.20.23
Featured Events